optalidon has been researched along with caffeine in 10 studies
*Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. [MeSH]
*Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. [MeSH]
| Studies (optalidon) | Trials (optalidon) | Recent Studies (post-2010) (optalidon) | Studies (caffeine) | Trials (caffeine) | Recent Studies (post-2010) (caffeine) |
|---|---|---|---|---|---|
| 11 | 0 | 1 | 25,501 | 2,393 | 6,825 |
| Protein | Taxonomy | optalidon (IC50) | caffeine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 7.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hopen, G; Ly, B; Moen, T | 1 |
| Gallerani, M; Menozzi, L; Monetti, VC; Montezemolo, A; Tola, MR; Zanotti, C | 1 |
| Audícana, MT; Garmendia, J; Joral, A; Muõz, D; Navarro, JA; Villas, F; Zubizarreta, J | 1 |
| Bravo, J; Fernandez, L; Garcia-Abujeta, JL; Jerez, J; Quiñones, D; Rodriguez, F; Sanchez, I | 1 |
| BONETTI, U | 1 |
| ROMAGNY, G | 1 |
| BERKEL, I; SAYRE, JW | 1 |
| LUTZ, W | 1 |
| Caldarola, G; Cozzani, E; Parodi, A; Pellicano, R | 1 |
| Biasucci, G; Capra, ME; Cirronis, M; DePaulis, NG; Locatelli, CA; Vezzoni, GM | 1 |
10 other study(ies) available for optalidon and caffeine
| Article | Year |
|---|---|
[Agranulocytosis caused by foreign analgesics (Optalidon and Nolotil)].
Topics: Administration, Oral; Agranulocytosis; Aminopyrine; Analgesics; Barbiturates; Butylscopolammonium Bromide; Caffeine; Dipyrone; Drug Combinations; Female; Humans; Middle Aged; Nonprescription Drugs; Pyrazoles; Spain | 1979 |
Barbiturate, analgesic, and caffeine withdrawal.
Topics: Adult; Aminopyrine; Anti-Inflammatory Agents, Non-Steroidal; Barbiturates; Caffeine; Coma; Drug Combinations; Female; Hallucinations; Humans; Substance Withdrawal Syndrome | 1994 |
Intradermal testing of fixed drug eruption.
Topics: Adult; Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Drug Eruptions; Female; Humans; Intradermal Tests; Male; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Erroneous diagnosis of idiopathic anaphylaxis.
Topics: Adult; Aminopyrine; Anaphylaxis; Barbiturates; Caffeine; Diagnostic Errors; Drug Combinations; Drug Hypersensitivity; Female; Humans | 1999 |
[Mental disorders caused by analgesic poisoning; description of a case caused by optalidon].
Topics: Aminopyrine; Analgesics; Barbiturates; Caffeine; Drug Combinations; Humans; Mental Disorders; Psychoses, Substance-Induced; Psychotic Disorders | 1958 |
[Two stage semeiology of optalidon poisoning; therapeutic results; study based on five personal cases in a pediatric service].
Topics: Aminopyrine; Barbiturates; Caffeine; Central Nervous System Agents; Child; Drug Combinations; Humans | 1959 |
OPTALIDON POISONING IN CHILDREN: A STUDY OF TWENTY CASES.
Topics: Aminopyrine; Barbiturates; Caffeine; Child; Drug Combinations; Humans; Infant; Toxicology; Turkey | 1964 |
[Extensive fixed exanthem caused by optalidon].
Topics: Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Drug Eruptions; Exanthema; Humans | 1951 |
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic.
Topics: Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Female; Glucocorticoids; Humans; Immunoglobulin A; Middle Aged; Prednisone; Skin Diseases, Vesiculobullous; Sunlight; Ultraviolet Rays | 2009 |
Neonatal abstinence syndrome and intra-uterine growth restriction secondary to maternal antimigraine drug abuse.
Topics: Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Male; Maternal Exposure; Neonatal Abstinence Syndrome; Substance-Related Disorders | 2021 |